AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
ALL-TRANS-RETINOIC ACID MODULATION OF DRUG-METABOLIZING ENZYME-ACTIVITIES - INVESTIGATION WITH SELECTIVE METABOLIC-DRUG PROBES
Authors: ADEDOYIN A STIFF DD SMITH DC ROMKES M BAHNSON RC DAY R HOFACKER J BRANCH RA TRUMP DL
Citation: A. Adedoyin et al., ALL-TRANS-RETINOIC ACID MODULATION OF DRUG-METABOLIZING ENZYME-ACTIVITIES - INVESTIGATION WITH SELECTIVE METABOLIC-DRUG PROBES, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 133-139
CHLOROQUINE MODULATION OF SPECIFIC METABOLIZING ENZYMES ACTIVITIES - INVESTIGATION WITH SELECTIVE 5 DRUG COCKTAIL
Authors: ADEDOYIN A FRYE RF MAURO K BRANCH RA
Citation: A. Adedoyin et al., CHLOROQUINE MODULATION OF SPECIFIC METABOLIZING ENZYMES ACTIVITIES - INVESTIGATION WITH SELECTIVE 5 DRUG COCKTAIL, British journal of clinical pharmacology, 46(3), 1998, pp. 215-219
USE OF CHLORZOXAZONE AS AN IN-VIVO PROBE OF CYTOCHROME-P450 2E1 - CHOICE OF DOSE AND PHENOTYPIC TRAIT MEASURE
Authors: FRYE RF ADEDOYIN A MAURO K MATZKE GR BRANCH RA
Citation: Rf. Frye et al., USE OF CHLORZOXAZONE AS AN IN-VIVO PROBE OF CYTOCHROME-P450 2E1 - CHOICE OF DOSE AND PHENOTYPIC TRAIT MEASURE, Journal of clinical pharmacology, 38(1), 1998, pp. 82-89
SELECTIVE EFFECT OF LIVER-DISEASE ON THE ACTIVITIES OF SPECIFIC METABOLIZING ENZYMES - INVESTIGATION OF CYTOCHROMES P450 2C19 AND 2D6
Authors: ADEDOYIN A ARNS PA RICHARDS WO WILKINSON GR BRANCH RA
Citation: A. Adedoyin et al., SELECTIVE EFFECT OF LIVER-DISEASE ON THE ACTIVITIES OF SPECIFIC METABOLIZING ENZYMES - INVESTIGATION OF CYTOCHROMES P450 2C19 AND 2D6, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 8-17
EFFECT OF STEROID-HORMONES ON CYP3A MEDIATED METABOLISM OF TERFENADINE
Authors: ALJENOOBI F ADEDOYIN A
Citation: F. Aljenoobi et A. Adedoyin, EFFECT OF STEROID-HORMONES ON CYP3A MEDIATED METABOLISM OF TERFENADINE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 43-43
SELECTIVE ALTERATION OF SPECIFIC METABOLIZING ENZYME-ACTIVITIES BY DISULFIRAM AND KETOCONAZOLE
Authors: ADEDOYIN A TRUMP DL BRUFSKY A FRYE RF HOFACKER J BRANCH RA
Citation: A. Adedoyin et al., SELECTIVE ALTERATION OF SPECIFIC METABOLIZING ENZYME-ACTIVITIES BY DISULFIRAM AND KETOCONAZOLE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 67-67
A PHASE-II TRIAL OF ALL-TRANS-RETINOIC ACID IN HORMONE-REFRACTORY PROSTATE-CANCER - A CLINICAL-TRIAL WITH DETAILED PHARMACOKINETIC ANALYSIS
Authors: TRUMP DL SMITH DC STIFF D ADEDOYIN A DAY R BAHNSON RR HOFACKER J BRANCH RA
Citation: Dl. Trump et al., A PHASE-II TRIAL OF ALL-TRANS-RETINOIC ACID IN HORMONE-REFRACTORY PROSTATE-CANCER - A CLINICAL-TRIAL WITH DETAILED PHARMACOKINETIC ANALYSIS, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 349-356
PHARMACOKINETIC PROFILE OF ABELCET (AMPHOTERICIN-B LIPID COMPLEX INJECTION) - COMBINED EXPERIENCE FROM PHASE-I AND PHASE-II STUDIES
Authors: ADEDOYIN A BERNARDO JF SWENSON CE BOLSACK LE HORWITH G DEWIT S KELLY E KLASTERKSY J SCULIER JP DEVALERIOLA D ANAISSIE E LOPEZBERESTEIN G LLANOSCUENTAS A BOYLE A BRANCH RA
Citation: A. Adedoyin et al., PHARMACOKINETIC PROFILE OF ABELCET (AMPHOTERICIN-B LIPID COMPLEX INJECTION) - COMBINED EXPERIENCE FROM PHASE-I AND PHASE-II STUDIES, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2201-2208
MEPHENYTOIN DISPOSITION AND SERUM BILE-ACIDS AS INDEXES OF HEPATIC-FUNCTION IN CHRONIC VIRAL-HEPATITIS
Authors: ARNS PA ADEDOYIN A DIBISCEGLIE AM WAGGONER JG HOOFNAGLE JH WILKINSON GR BRANCH RA
Citation: Pa. Arns et al., MEPHENYTOIN DISPOSITION AND SERUM BILE-ACIDS AS INDEXES OF HEPATIC-FUNCTION IN CHRONIC VIRAL-HEPATITIS, Clinical pharmacology and therapeutics, 62(5), 1997, pp. 527-537
VALIDATION OF THE 5-DRUG PITTSBURGH COCKTAIL APPROACH FOR ASSESSMENT OF SELECTIVE REGULATION OF DRUG-METABOLIZING-ENZYMES
Authors: FRYE RF MATZKE GR ADEDOYIN A PORTER JA BRANCH RA
Citation: Rf. Frye et al., VALIDATION OF THE 5-DRUG PITTSBURGH COCKTAIL APPROACH FOR ASSESSMENT OF SELECTIVE REGULATION OF DRUG-METABOLIZING-ENZYMES, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 365-376
CYP2D6 MESSENGER-RNA EXPRESSION IN CIRCULATING PERIPHERAL-BLOOD MONONUCLEAR-CELLS CORRELATES WITH IN-VIVO DEBRISOQUINE HYDROXYLASE-ACTIVITYIN EXTENSIVE METABOLIZERS
Authors: CARCILLO JA PARISE RA ADEDOYIN A FRYE R BRANCH RA ROMKES M
Citation: Ja. Carcillo et al., CYP2D6 MESSENGER-RNA EXPRESSION IN CIRCULATING PERIPHERAL-BLOOD MONONUCLEAR-CELLS CORRELATES WITH IN-VIVO DEBRISOQUINE HYDROXYLASE-ACTIVITYIN EXTENSIVE METABOLIZERS, Research communications in molecular pathology and pharmacology, 91(2), 1996, pp. 149-159
METABOLIC INTERACTIONS OF PUTATIVE CYTOCHROME P4503A SUBSTRATES WITH ALTERNATIVE PATHWAYS OF DAPSONE METABOLISM IN HUMAN LIVER-MICROSOMES
Authors: IRSHAID Y BRANCH RA ADEDOYIN A
Citation: Y. Irshaid et al., METABOLIC INTERACTIONS OF PUTATIVE CYTOCHROME P4503A SUBSTRATES WITH ALTERNATIVE PATHWAYS OF DAPSONE METABOLISM IN HUMAN LIVER-MICROSOMES, Drug metabolism and disposition, 24(2), 1996, pp. 164-171
DIFFERENTIAL INHIBITION OF 2 OXIDATIVE METABOLIC PATHWAYS OF DAPSONE BY AZOLE ANTIFUNGALS
Authors: ALGENOUBY F KIRILLOVA GP VENKATARAMANAN R BRANCH RA ADEDOYIN A
Citation: F. Algenouby et al., DIFFERENTIAL INHIBITION OF 2 OXIDATIVE METABOLIC PATHWAYS OF DAPSONE BY AZOLE ANTIFUNGALS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 23-23
DIFFERENTIAL EFFECT OF QUINIDINE AND RIFAMPIN ON 2 OXIDATIVE METABOLITES OF DAPSONE
Authors: ADEDOYIN A KIRILLOVA GP BRANCH RA
Citation: A. Adedoyin et al., DIFFERENTIAL EFFECT OF QUINIDINE AND RIFAMPIN ON 2 OXIDATIVE METABOLITES OF DAPSONE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 29-29
EFFECTS OF CONTINUOUS INHIBIN ADMINISTRATION ON GONADOTROPIN-SECRETION AND SUBUNIT GENE-EXPRESSION IN IMMATURE AND ADULT MALE-RATS
Authors: WINTERS SJ POHL CR ADEDOYIN A MARSHALL GR
Citation: Sj. Winters et al., EFFECTS OF CONTINUOUS INHIBIN ADMINISTRATION ON GONADOTROPIN-SECRETION AND SUBUNIT GENE-EXPRESSION IN IMMATURE AND ADULT MALE-RATS, Biology of reproduction, 55(6), 1996, pp. 1377-1382
THE PROCARCINOGEN HYPOTHESIS FOR BLADDER-CANCER - ACTIVITIES OF INDIVIDUAL-DRUG METABOLIZING ENZYMES AS RISK-FACTORS
Authors: BRANCH RA CHERN HD ADEDOYIN A ROMKESSPARKS M LESNICK TG PERSAD R WILKINSON GR FLEMING CM DICKINSON AJ SIBLEY G SMITH P
Citation: Ra. Branch et al., THE PROCARCINOGEN HYPOTHESIS FOR BLADDER-CANCER - ACTIVITIES OF INDIVIDUAL-DRUG METABOLIZING ENZYMES AS RISK-FACTORS, Pharmacogenetics, 5, 1995, pp. 97-102
SELECTIVE MODULATION OF SPECIFIC METABOLIZING ACTIVITIES BY CHLOROQUINE
Authors: ADEDOYIN A MAURO K FRYE R PORTER J BRANCH RA
Citation: A. Adedoyin et al., SELECTIVE MODULATION OF SPECIFIC METABOLIZING ACTIVITIES BY CHLOROQUINE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 150-150
MODULATION OF N-ACETYLTRANSFERASE ACTIVITY BY ALL-TRANS-RETINOIC ACIDIN FAST BUT NOT SLOW ACETYLATORS
Authors: STIFF D ADEDOYIN A ROMKESSPARKS M PORTER J SMITH D TRUMP D BRANCH RA
Citation: D. Stiff et al., MODULATION OF N-ACETYLTRANSFERASE ACTIVITY BY ALL-TRANS-RETINOIC ACIDIN FAST BUT NOT SLOW ACETYLATORS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 182-182
CHRONIC MODULATION OF CYP2D6 AND CYP3A4 ACTIVITIES BY QUINIDINE AND RIFAMPICIN RESPECTIVELY
Authors: ADEDOYIN A MAURO K KUBISTY C BOYER A PORTER J BRANCH RA
Citation: A. Adedoyin et al., CHRONIC MODULATION OF CYP2D6 AND CYP3A4 ACTIVITIES BY QUINIDINE AND RIFAMPICIN RESPECTIVELY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 210-210
NONLINEAR PHARMACOKINETICS OF CHLORZOXAZONE IN HUMANS
Authors: FRYE RF MAURO K ADEDOYIN A MATZKE GR BRANCH RA
Citation: Rf. Frye et al., NONLINEAR PHARMACOKINETICS OF CHLORZOXAZONE IN HUMANS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 217-217
GENETIC AND ENVIRONMENTAL-FACTORS IN LUNG-CANCER SUSCEPTIBILITY
Authors: RITTMEYER L YANG P SCHWARTZ AG ADEDOYIN A ROMKES M LANDRENEAU R MAURO K BRANCH R
Citation: L. Rittmeyer et al., GENETIC AND ENVIRONMENTAL-FACTORS IN LUNG-CANCER SUSCEPTIBILITY, American journal of human genetics, 57(4), 1995, pp. 408-408
LOW ACTIVITY OF DAPSONE N-HYDROXYLATION AS A SUSCEPTIBILITY RISK FACTOR IN AGGRESSIVE BLADDER-CANCER
Authors: FLEMING CM PERSAD R KAISARY A SMITH P ADEDOYIN A PORTER J WILKINSON GR BRANCH RA
Citation: Cm. Fleming et al., LOW ACTIVITY OF DAPSONE N-HYDROXYLATION AS A SUSCEPTIBILITY RISK FACTOR IN AGGRESSIVE BLADDER-CANCER, Pharmacogenetics, 4(4), 1994, pp. 199-207
STEREOSELECTIVE DISPOSITION OF HEXOBARBITAL AND ITS METABOLITES - RELATIONSHIP TO THE S-MEPHENYTOIN POLYMORPHISM IN CAUCASIAN AND CHINESE SUBJECTS
Authors: ADEDOYIN A PRAKASH C OSHEA D BLAIR IA WILKINSON GR
Citation: A. Adedoyin et al., STEREOSELECTIVE DISPOSITION OF HEXOBARBITAL AND ITS METABOLITES - RELATIONSHIP TO THE S-MEPHENYTOIN POLYMORPHISM IN CAUCASIAN AND CHINESE SUBJECTS, Pharmacogenetics, 4(1), 1994, pp. 27-38
MONOACETYLDAPSONE INHIBITION OF DAPSONE N-HYDROXYLATION BY HUMAN AND RAT-LIVER MICROSOMES
Authors: IRSHAID Y ADEDOYIN A LOTZE M BRANCH RA
Citation: Y. Irshaid et al., MONOACETYLDAPSONE INHIBITION OF DAPSONE N-HYDROXYLATION BY HUMAN AND RAT-LIVER MICROSOMES, Drug metabolism and disposition, 22(1), 1994, pp. 161-164
METABOLIC INTERACTIONS BETWEEN CYTOCHROME P4503A SUBSTRATES
Authors: IRSHAID Y ADEDOYIN A BRANCH RA
Citation: Y. Irshaid et al., METABOLIC INTERACTIONS BETWEEN CYTOCHROME P4503A SUBSTRATES, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 139-139
Risultati: 1-25 | 26-26